Newron Pharmaceuticals
NWRN.SW
#8333
Rank
HK$1.33 B
Marketcap
HK$66.50
Share price
-0.42%
Change (1 day)
1.61%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -HK$8.40

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$8.40. In 2023 the company made an earnings per share (EPS) of -HK$8.40 a decrease over its 2022 EPS that were of -HK$8.23.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-HK$8.402.03%
2022-HK$8.2315.39%
2021-HK$7.13-31.32%
2020-HK$10.3814.74%
2019-HK$9.0536.6%
2018-HK$6.62159.87%
2017-HK$2.55-67.81%
2016-HK$7.92-39.24%
2015-HK$13.03107.61%
2014-HK$6.2815.8%
2013-HK$5.42119.91%
2012-HK$2.46-66.51%
2011-HK$7.36-71.49%
2010-HK$25.81-10.83%
2009-HK$28.9542.06%
2008-HK$20.3856.53%
2007-HK$13.02-52.84%
2006-HK$27.61-188.53%
2005HK$31.19